Trial
NCT06017323
Proglumide With Gemcitabine and Nab-Paclitaxel in PatientsWith Metastatic Pancreatic Ductal Adenocarcinoma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Georgetown University
Collaborators
—
Condition
Metastatic Pancreatic Cancer
Intervention
Gemcitabine
Why stopped
STUDY00006987
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-25